Literature DB >> 19448211

Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation.

Kerstin D Röhm1, Andinet Mengistu, Joachim Boldt, Jochen Mayer, Grietje Beck, Swen N Piper.   

Abstract

BACKGROUND: Increased inorganic fluoride levels after methoxyflurane exposure in the 1970s and prolonged intraoperative sevoflurane use have been suggested to be potentially nephrotoxic. In the intensive care unit we evaluated the effect on renal integrity of short-term inhaled postoperative sedation with sevoflurane using the Anesthetic Conserving Device (ACD) compared with propofol.
METHODS: In this prospective, randomized, single-blinded study, after major abdominal, vascular or thoracic surgery 125 patients were allocated to receive either sevoflurane (n = 64) via the ACD (end-tidal 0.5-1 vol%) or i.v. propofol (n = 61) for postoperative sedation up to 24 h. Urinary alpha-glutathione-s-transferase as primary outcome variable, urinary N-acetyl-glucosaminidase, serum creatinine, and inorganic fluoride concentrations, urine output and fluid management were measured preoperatively, at the end of surgery, and at 24 and 48 h postoperatively.
RESULTS: The sedation time in the intensive care unit was comparable between the sevoflurane (9.2 +/- 4.3 h) and the propofol (9.3 +/- 4.7 h) group. Alpha-glutathione-s-transferase levels were significantly increased at 24 and 48 h postoperatively compared with preoperative values in both groups, without significant differences between the groups. N-acetyl-glucosaminidase and serum creatinine remained unchanged in both study groups, and urine output and creatinine clearance were comparable between the groups throughout the study period. Inorganic fluoride levels increased significantly (P < 0.001) at 24 h after sevoflurane exposure (39 +/- 25 micromol/L) compared with propofol (3 +/- 6 micromol/L) and remained elevated 48 h later (33 +/- 26 vs 3 +/- 5 micromol/L). One patient in each group suffered from renal insufficiency, requiring intensive diuretic therapy, but not dialysis, during hospital stay.
CONCLUSIONS: Short-term sedation with either sevoflurane using ACD or propofol did not negatively affect renal function postoperatively. Although inorganic fluoride levels were elevated after sevoflurane exposure, glomerular and tubular renal integrity were preserved throughout the hospital stay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448211     DOI: 10.1213/ane.0b013e3181a1988b

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  17 in total

1.  Evaluating the efficiency of desflurane reflection in two commercially available reflectors.

Authors:  Hagen Bomberg; Marcel Wessendorf; Martin Bellgardt; Max Veddeler; Stefan Wagenpfeil; Thomas Volk; Heinrich V Groesdonk; Andreas Meiser
Journal:  J Clin Monit Comput       Date:  2016-07-08       Impact factor: 2.502

2.  Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure.

Authors:  Julian Bösel; Jan C Purrucker; Frank Nowak; Julian Renzland; Petra Schiller; Eva Benveniste Pérez; Sven Poli; Benjamin Brunn; Werner Hacke; Thorsten Steiner
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

3.  Perioperative Clinical Trials in AKI.

Authors:  David R McIlroy; Marcos G Lopez; Frederic T Billings
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

4.  The volatile anesthetic sevoflurane attenuates ventilator-induced lung injury through inhibition of ERK1/2 and Akt signal transduction.

Authors:  Sang-Hun Kim; Mei Li; Tae-Hee Pyeon; Keum-Young So; Sang-Hyun Kwak
Journal:  Korean J Anesthesiol       Date:  2015-01-28

5.  A novel device for target controlled administration and reflection of desflurane--the Mirus™.

Authors:  H Bomberg; M Glas; V H Groesdonk; M Bellgardt; J Schwarz; T Volk; A Meiser
Journal:  Anaesthesia       Date:  2014-07-09       Impact factor: 6.955

6.  Post-conditioning: promising answers and more questions.

Authors:  David Bracco
Journal:  Crit Care       Date:  2012-11-23       Impact factor: 9.097

7.  A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa(®) device.

Authors:  Satyajeet Misra; Thomas Koshy
Journal:  Indian J Anaesth       Date:  2012-11

8.  Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive care patients: study protocol for a randomized controlled trial.

Authors:  Jens Soukup; Antje Selle; Andreas Wienke; Jörg Steighardt; Nana-Maria Wagner; Patrick Kellner
Journal:  Trials       Date:  2012-08-10       Impact factor: 2.279

9.  Sedation with sevoflurane in postoperative cardiac surgery: influence on troponin T and creatinine values.

Authors:  J M Marcos-Vidal; R González; C Garcia; C Soria; M Galiana; B De Prada
Journal:  Heart Lung Vessel       Date:  2014

10.  AnaConDa™ and Mirus™ for intensive care sedation, 24 h desflurane versus isoflurane in one patient.

Authors:  Hagen Bomberg; Heinrich V Groesdonk; Martin Bellgardt; Thomas Volk; Andreas Meiser
Journal:  Springerplus       Date:  2016-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.